ES404799A3 - A procedure for the manufacture of insulin preparations with controlled effect. (Machine-translation by Google Translate, not legally binding)
- Google Patents
A procedure for the manufacture of insulin preparations with controlled effect. (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VAMCO CIVIL PARTICULA Soc
Original Assignee
VAMCO CIVIL PARTICULA Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VAMCO CIVIL PARTICULA SocfiledCriticalVAMCO CIVIL PARTICULA Soc
Priority to ES404799ApriorityCriticalpatent/ES404799A3/en
Publication of ES404799A3publicationCriticalpatent/ES404799A3/en
A procedure for manufacturing insulin preparations with a prolonged effect, characterized in that an amorphous or crystalline, or both amorphous and crystalline, insulin with a chemically fixed zinc content of 3 to 10 is suspended in an aqueous liquid, suitable for injections, free of zinc. 8%, with which a separation of zinc occurs, and the suspended insulin remains unaffected with a ph value of the liquid around 7. (Machine-translation by Google Translate, not legally binding)
ES404799A1972-07-121972-07-12A procedure for the manufacture of insulin preparations with controlled effect. (Machine-translation by Google Translate, not legally binding)
ExpiredES404799A3
(en)
Process for the preparation of a member of the group consisting of a salt of furaltadone acid pamoate and a hydrate of the same (Machine-translation by Google Translate, not legally binding)